Glibenclamide/metformin
| Combination of | |
|---|---|
| Glibenclamide | Sulfonylurea |
| Metformin | Biguanide |
| Clinical data | |
| Trade names | Glucovance |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a699055 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.[6] It contains glibenclamide, a sulfonylureas, and metformin, a biguanide.[7]
References
- 1 2 "TGA eBS - Product and Consumer Medicine Information Licence".
- ↑ "Search the TGA website".
- ↑ "Search the TGA website".
- ↑ "Search the TGA website".
- ↑ "Glucovance- glyburide and metformin hydrochloride tablet, film coated". DailyMed. 23 April 2012. Retrieved 30 April 2022.
- ↑ Lamos EM, Stein SA, Davis SN (December 2012). "Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus". Expert Opinion on Pharmacotherapy. 13 (17): 2545–54. doi:10.1517/14656566.2012.738196. PMID 23116560. S2CID 10305382.
- ↑ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Retrieved 11 August 2020.
External links
- "Glyburide mixture with Metformin hydrochloride". Drug Information Portal. U.S. National Library of Medicine.
This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.